PAR-25-171-Full-Announcement.html

This document is a Notice of Funding Opportunity (NOFO) for the Cancer Tissue Engineering Collaborative (TEC) Research Program, which is sponsored by the National Cancer Institute (NCI), an agency within the Department of Health and Human Services National Institutes of Health.

The NOFO seeks to support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects engaging fields such as regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology are essential. The projects will collectively participate in the Cancer TEC Research Program, which aims to catalyze the advancement of innovative, well-characterized in vitro and ex vivo systems for cancer research, expand the breadth of these systems to several cancer types, and promote the exploration of cancer phenomena with biomimetic tissue-engineered systems. Eligible applicant types include for-profit organizations, nonprofits, higher education institutions, state/local governments, and small businesses. The funding instruments are grants, and the relevant federal grant programs are Cancer Detection and Diagnosis Research, Cancer Treatment Research, Cancer Cause and Prevention Research, Cancer Control, and Cancer Biology Research.